Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Mar 30, 2010

Premium

Steve Lincoln has joined Complete Genomics as vice president of scientific applications. He previously served as vice president of informatics at Affymetrix, executive vice president of product development and CSO of InforMax, and vice president of bioinformatics R&D at Incyte.


Frank Pitzer has been appointed as CEO of Roche NimbleGen, which is part of Roche Applied Science, a unit of Roche Diagnostics. Most recently, he was head of divisional quality and regulatory affairs at Roche Diagnostics. Pitzer holds a PhD in biology from the Max Planck Institute for Biochemistry.


Dian Donnai has won the 2010 March of Dimes/Colonel Harland Sanders award for her lifetime achievement in the field of genetic sciences. She is a professor of medical genetics at the University of Manchester in the UK and the president of the European Society for Human Genetics. She is also the clinical head of St. Mary's Hospital in the Central Manchester University Hospitals NHS Trust, which includes the Genetic Medicine Center. Donnai is known for her research on rare genetic diseases, such as Williams syndrome.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.